Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
暂无分享,去创建一个
Emiliano Santarnecchi | Daniel Z Press | Susan T Herman | D. Press | E. Santarnecchi | M. Shafi | S. Herman | C. Musaeus | Christian S Musaeus | Mouhsin M Shafi
[1] Charles Hall,et al. Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care , 2010, Alzheimer disease and associated disorders.
[2] Amy L. Shelton,et al. Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.
[3] J. Morris,et al. Advanced Alzheimer's disease is a risk factor for late-onset seizures. , 1990, Archives of neurology.
[4] V. Buckles,et al. Understanding of informed consent by demented individuals , 2003, Neurology.
[5] C. Babiloni,et al. Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms , 2006, Neuroscience.
[6] D. Lozsádi,et al. Prevalence and Causes of Seizures at the Time of Diagnosis of Probable Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.
[7] Neri Accornero,et al. Clinical, Cognitive, and Neurophysiologic Correlates of Short-Term Treatment with Carbamazepine, Oxcarbazepine, and Levetiracetam in Healthy Volunteers , 2004, The Annals of pharmacotherapy.
[8] A. Nordberg,et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease , 2000, Neurobiology of Aging.
[9] Sung-chul Lim,et al. Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam , 2015, Neuropsychiatric disease and treatment.
[10] Hong-Guang Xie,et al. Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice , 2013, CNS neuroscience & therapeutics.
[11] Vladimir Krajca,et al. Objective Assessment of the Degree of Dementia by Means of EEG , 2003, Neuropsychobiology.
[12] Chien-Yeh Hsu,et al. Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer's disease: A multicenter analysis in Taiwan. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.
[13] Arnaud Delorme,et al. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis , 2004, Journal of Neuroscience Methods.
[14] Jaeseung Jeong. EEG dynamics in patients with Alzheimer's disease , 2004, Clinical Neurophysiology.
[15] P. G. Larsson,et al. Decrease in Propagation of Interictal Epileptiform Activity After Introduction of Levetiracetam Visualized with Electric Source Imaging , 2010, Brain Topography.
[16] D Liberati,et al. EEG coherence in Alzheimer's disease. , 1998, Electroencephalography and clinical neurophysiology.
[17] Yaakov Stern,et al. Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.
[18] Caroline L. Speck,et al. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance , 2015, NeuroImage: Clinical.
[19] K. Nocka,et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Petersen,et al. Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome , 2009, Epilepsy & Behavior.
[21] H. Adeli,et al. Intrahemispheric, interhemispheric, and distal EEG coherence in Alzheimer’s disease , 2011, Clinical Neurophysiology.
[22] L. Mucke,et al. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.
[23] S. Bernardi,et al. Seizures in Alzheimer’s disease: a retrospective study of a cohort of outpatients , 2010, Epileptic disorders : international epilepsy journal with videotape.
[24] Ki-Young Jung,et al. Region and frequency specific changes of spectral power in Alzheimer’s disease and mild cognitive impairment , 2011, Clinical Neurophysiology.
[25] Hyunmi Choi,et al. Seizures in Alzheimer disease: who, when, and how common? , 2009, Archives of neurology.
[26] M. Mendez,et al. Seizures in Elderly Patients with Dementia , 2003, Drugs & aging.
[27] Heidi E Kirsch,et al. Incidence and impact of subclinical epileptiform activity in Alzheimer's disease , 2016, Annals of neurology.
[28] T. Gasser,et al. EEG coherence in Alzheimer disease. , 1994, Electroencephalography and clinical neurophysiology.
[29] M S Buchsbaum,et al. Topographic EEG changes with normal aging and SDAT. , 1989, Electroencephalography and clinical neurophysiology.
[30] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[31] Terrence J. Sejnowski,et al. Independent Component Analysis Using an Extended Infomax Algorithm for Mixed Subgaussian and Supergaussian Sources , 1999, Neural Computation.
[32] A. Ebner,et al. Effect of Levetiracetam on Epileptiform Discharges in Human Neocortical Slices , 2002, Epilepsia.
[33] Yong He,et al. BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics , 2013, PloS one.
[34] B. Steinhoff,et al. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges , 2001, Seizure.
[35] L. Volicer,et al. Effect of seizures on progression of dementia of the Alzheimer type. , 1995, Dementia.
[36] Claudio Babiloni,et al. Cortical networks generating movement-related EEG rhythms in Alzheimer's disease: an EEG coherence study. , 2004, Behavioral neuroscience.
[37] W. Hauser,et al. Seizures and myoclonus in patients with Alzheimer's disease , 1986, Neurology.
[38] D. Irwin,et al. Levetiracetam: A Practical Option for Seizure Management in Elderly Patients With Cognitive Impairment , 2010, American journal of Alzheimer's disease and other dementias.
[39] F H Duffy,et al. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type , 1984, Annals of neurology.
[40] M. Storandt,et al. A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years. , 1985, Electroencephalography and clinical neurophysiology.
[41] C. J. Stam,et al. Global dynamical analysis of the EEG in Alzheimer’s disease: Frequency-specific changes of functional interactions , 2008, Clinical Neurophysiology.
[42] Keith A. Vossel,et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model , 2012, Proceedings of the National Academy of Sciences.
[43] J D Van Horn,et al. A comparison of rCBF patterns during letter and semantic fluency. , 2000, Neuropsychology.
[44] L. Mucke,et al. Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.
[45] S. Hong,et al. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients , 2012, Clinical Neurophysiology.